Effect of Ramosetron on Remifentanil for Preventing Emergence Cough in Female

Effect of ramosetron on effect-site concentration of remifentanil for preventing emergence cough during general anesthesia in female patients undergoing laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005441

Enrollment

Registered

2020-09-25

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Control group receives the intravenous normal saline 2 mL. Ramosetron group receives the intravenous Ramosetron 2 mL (0.3 mg).

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Laparoscopic cholecystectomy under general anesthesia

Exclusion criteria

Exclusion criteria: BMI > 30 kg/m2, respiratory infection, uncontrolled hypertension

Design outcomes

Primary

Measure	Time frame
optimal Ce of remifentanil	—

Secondary

Measure	Time frame
complications, emergence time, pain score	—

Countries

Korea, Republic of

Contacts

Public ContactJi Kim

Ajou University Hospital

Outcome results